Skip to content

Mirum Pharmaceuticals, Inc. MIRM Total Cost of Revenue

Total Cost of Revenue at other companies

Gilead Sciences logo
Gilead SciencesGILD
$1.45B-6.2%
Alkermes logo
AlkermesALKS
$61.58M+25.2%
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$2.98M+104%
TG Therapeutics logo
TG TherapeuticsTGTX
$33.51M+116%
Rhythm Pharmaceuticals, Inc. logo
Rhythm Pharmaceuticals, Inc.RYTM
LQD
Liquidia CorporationLQDA

Segments

By segment

See full
Reportable Segment$22.12M+29.2%

Other financials

Income statement

See full
Revenue$159.9M+43.3%
Operating income-$789.5M-5,100%
Net income-$790.2M-5,284%
EPS (diluted)-$13.43-4,377%

Balance sheet

See full
Cash & equivalents$261.5M+43.5%
Total debt$13.5M+56.4%
Total equity$242.5M+4.0%
Total assets$890.9M+29.1%

Cash flow

See full
Operating cash flow-$228.8M-11,566%
CapEx$664.0K+1,520%
Free cash flow-$229.4M-11,360%

Valuation

See full
Market cap$6.53B+152%
Enterprise value$6.28B+162%
P/S11.5×+4.6×

Profitability

See full
Operating margin-139.8%-168pp
Net margin-140.2%-169pp
FCF margin-30.3%

Returns & leverage

See full
Return on equity-335.8%-377pp
Debt / equity0.1×0.0×
Current ratio2.1×-1.1×

Questions, answered.

What does total cost of revenue mean?
The aggregate of all direct costs attributable to producing goods and delivering services that generated the company's revenue, including materials, labor, and overhead.